KP-302 ( Synonyms: Lucid-21-302 ; Lucid-MS ) is a small molecule inhibitor of protein-arginine deiminase enzymes in phase I development as oral treatment for multiple sclerosis. The compound acts by inhibiting the conversion of arginine into citrulline (deimination or citrullination). Enzymes involved in citrullination have been reported to alter myelin structure and to correlate with multiple sclerosis severity.
For research use only. We do not sell to patients.
Name | KP-302 ( Synonyms: Lucid-21-302 ; Lucid-MS ) |
---|---|
Iupac Chemical Name | (S)-N-(1-(benzylamino)-4-(imidazol-1-yl)-1-oxobutan-2-yl)-1-methyl-pyrrole-2-carboxamide |
Synonyms | KP-302 ; Lucid-21-302 ; Lucid-MS ; KP302 ; KP 302 |
Molecular Formula | C20H23N5O2 |
Molecular Weight | 365.44 |
Smile | O=C(C1=CC=CN1C)N[C@@H](CCN2C=CN=C2)C(NCC3=CC=CC=C3)=O |
InChiKey | XLISVTDEJLYVTB-KRWDZBQOSA-N |
InChi | InChI=1S/C20H23N5O2/c1-24-11-5-8-18(24)20(27)23-17(9-12-25-13-10-21-15-25)19(26)22-14-16-6-3-2-4-7-16/h2-8,10-11,13,15,17H,9,12,14H2,1H3,(H,22,26)(H,23,27)/t17-/m0/s1 |
CAS Number | 2082765-42-0 |
Related CAS | 2082765-42-0 |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Solid powder |
---|---|
Purity | ≧98.0% |
Storage | Dry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years). |
Solubility | Soluble in DMSO |
Handling | Refer to MSDS |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
HS Code | 2934200090 |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |